Elicasal Ointment is an effective topical medication that combines two active ingredients that work together to treat a variety of skin conditions characterized by inflammation and itching. The ointment contains 0.1% mometasone furoate, a powerful corticosteroid that helps reduce inflammation, itching, swelling, and redness. It also contains 5% salicylic acid, a keratolytic that helps remove flaky, dead skin, allowing mometasone to better penetrate the deeper layers of the skin and increase its effectiveness. Elicasal Ointment is used to relieve the symptoms of inflammation and itching associated with many skin conditions.
The active ingredient in Elicasal Ointment:
Each gram of Elicasal Ointment contains the following two active ingredients, which are responsible for its therapeutic effect:
Mometasone furoate: 0.1% (equivalent to 1 mg of mometasone furoate per gram of ointment).
Salicylic Acid: 5% (equivalent to 50 mg of salicylic acid per gram of ointment).
Mechanism of Action of Elicasal Ointment
Elicasal Ointment works through two distinct but complementary mechanisms thanks to the presence of its two active ingredients:
Mometasone furoate: A powerful topical corticosteroid that works by inhibiting the production of chemicals that cause inflammation in the skin, such as prostaglandins and cytokines. It helps reduce the redness, swelling, itching, and discomfort associated with skin inflammation.
Salicylic Acid: A keratolytic, meaning it helps soften and break down the thick, scaly outer layer of the skin. This helps remove dead, scaly skin, allowing mometasone to penetrate deeper layers of the skin where inflammation is most effective. Salicylic acid also has a mild anti-inflammatory effect and may help prevent the growth of certain microorganisms. This combination provides effective treatment for skin conditions characterized by inflammation and scaling.
Indications for Use of Elicasal Ointment
Elicasal Ointment is used to treat a variety of skin conditions that respond to topical corticosteroids and are characterized by scaling or thickening of the stratum corneum, including:
Psoriasis, including scalp psoriasis and chronic stable psoriasis.
Chronic eczema, including atopic dermatitis and chronic contact dermatitis, which are characterized by scaling and thickening of the skin.
Ichthyosis and other skin disorders characterized by scaling.
Other skin conditions that respond to topical corticosteroids and are characterized by thickening or scaling of the stratum corneum.
Elicasal Ointment should only be used upon prescription from a dermatologist.